#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Surgical Management of the Colorectal Carcinoma Liver Metastases


Authors: V. Třeška;  T. Skalický;  A. Sutnar;  V. Liška
Authors‘ workplace: Chirurgická klinika FN v Plzni, přednosta: prof. MUDr. Vladislav Třeška, DrSc.
Published in: Rozhl. Chir., 2009, roč. 88, č. 2, s. 69-74.
Category: Monothematic special - Original

Overview

Introduction:
Unfortunately, the Czech Republic rates of the colorectal carcinoma are the highest in the world. Surgical procedures for colorectal carcinoma liver metastases (JMKRK) are well established and have good long-term outcomes.

Aim:
The aim of the study was to assess own results with a reference on modern trends in liver surgery.

Subjects and Methodology:
From 01- 01- 2000 to 01-12- 2008, a total of 442 liver procedures in 346 patients with colorectal carcinoma liver metastases were performed in the Faculty Hospital and the Charles University Medical Faculty Surgical Clinic in Plzeň.

Results:
The 30-day postoperative mortality rate was 0.3 %, the morbidity rate was 8.1 %. Five years following the liver procedure for the colorectal carcinoma liver metastases, 34.0% of the subjects are surviving. 3 years following radiofrequency ablation (RFA) of the colorectal carcinoma liver metastases, 35.5% of the patients are surviving.

Conclusion:
Nowadays, surgical management of the colorectal carcinoma liver metastases is the method of choice. The other alternative is radiofrequency ablation (RFA) in non-resectable colorectal carcinoma liver metastases. However, currently, only 20% of the patients are operable using the radical methods at the time, when the diagnosis is established. Therefore, the new trends in liver surgery include several-stage/phase, combined procedures and re-resections, aimed to improve resecability of the colorectal carcinoma liver metastases with low patient postoperative mortality and morbility rates.

Key words:
colorectal carcinoma liver metastases (JMKRK) – surgical management


Sources

1. Novotvary 2003 ČR: ÚZIS ČR 2006, 58–84.

2. Havlíček, K., Šácha, M., Šiller, J., Sákra, L., Rajman, M., Beránek, K. K-ras mutace u kolorektálního karcinomu jako prognostický faktor vývoje onemocnění. Slov. Chir., 3; 2005, s. 8–12.

3. McLoughlin, J. M., Jensen, E. H., Malafa, M. Resection of colorectal liver metastases: Current perspectives. Cancer Control, 13; 2006, 32–41.

4. Ruers, T., Bleichrodt, R. P. Treatment of liver metastases, an update on the possibilities and results. Eur. J. Cancer, 38; 2002, 1023–1033.

5. Adam, R., Ducreux, M., Rougier, P., Chaibi, P., Mariette, C. Management of colorectal cancer and its metastases rot he liver. J. Chir., 145 Suppl. 1, 1–4.

6. Hirai, I., Kimura, W., Fuse, A., Isobe, H., Hadiga,O., Moriya T., Suto, K. Surgical management for metastatic liver tumors. Hepatogastroenterology, 53; 2006, 757–763.

7. Grundmann, R. T., Hermanek, P., Merkem, S., Germer, C. T., Grundmann, R. T., Hauss, J., et al. Diagnosis and treatment of colorectal liver metastases. Zentralbl. Chir., 133; 2008, 267–284.

8. Kockerling, F., Schwartz, S. I. Liver Surgery. 1. vyd., Heidelberg, J. A. Barth, 2001, 51–65.

9. Choti, M. A., Sitzmann, J. V., Tiburi, M. F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg., 235; 2002, 759–766.

10. Skalický, T., Třeška, V., Šnajdauf, J. Chirurgie jater. l. vyd., Praha, Maxdorf-Jessenius, 2004, 86–110.

11. Třeška, V. Liver resection technice – current advances. Rozhl. Chir., 86; 2007, 333–335.

12. Adam, R., Delvart, V., Pascal, G., Valeanu, A., et al. Rescue surgery for unresectable colorectal liver metastases downstaged chemotherapy: a model to predict long-term survival. Ann. Surg., 240; 2004, 644–657.

13. Liu, L. X., Zhang, W. H., Jiang, H. C. Current treatment for liver metastases from colorectal cancer. World J. Gastroenetrolog., 2; 2003, 193–200.

14. De Haas, R. J., Wicherts, D. A., Flores, E., Azoulay, D., Castaing, D., Adam, R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to Sumery? Ann. Surg., 248; 2008, 626–637.

15. Adam, R., de Haas, R. J., Wicherts, D. A., Alaia, T. A., Delvart, V., Azoulay, D., Bismuth, H., Castaing, D. Is hepatic resection justified after chemotherapy in patiens with colorectal liver metastases and lymf node involvement? J. Clin. Oncol., 26; 2008: 3672–3680.

16. Jaeck, D., Pessaux, P. Bilobar colorectal liver metastases: treatment options. Surg. Oncol. Clin. N. Am., 17; 2008, 553–568.

17. Curley, S. A., Izzo, F., Abdalla, E., Vauthey, J. N. Surgical treatment of colorectal metastases. Cancer Metastasis Rev., 23, 2004, 165–182.

18. Khatri, V. P., Chee, K. G., Petrelli, N. J. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg. Oncol., 16; 2007, 71–83.

19. Giraudo, G., Greget, M, Oussoultroglou, E., Rosso, E., Bachellier, P, Jaeck, D. Preoperative contralateral portal vein embolization efore major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery, 143; 2008, 476–482.

20. Bismuth, H., Adam, R., Vibert, E. Chemotherapy of liver metastasis from colorectal cancer. Bull. Acad. Natl. Med., 191; 2007, 1647–1660.

21. Třeška, V., Skalický, T., Liška, V., Ferda, J. Repeated procedures for colorectal liver metastases. Hepatogastroenterology, 54; 2007, 1741–1744.

22. Skalický, T., Třeška, V. Radiofrekvenční ablace jaterních nádorů. 1. vyd., Praha, Maxdorf-Jessenius, 2006, 21–36.

23. Wong, S. L.,Edwards, M. J., Chao, C. Radiofrequency ablation for unresectable hepatic tumors. Am. J. Surg., 182; 2001, 552–557.

24. Valtri, A., Sacchetto, P., Tosetti, I., Pagano, E., Fava, C., Gandini, G. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technice effectiveness and survival. Cardiovasc. Intervent. Radiol., 31; 2008, 948–956.

25. Lee, W. S., Yun, S. H., Chun, H. K., Lee, W. Y., Kim, S. J., Chai, S. H., Heo, J. S., Joh, J. W. Clinical outcomes of hepatic ablation in patiens with solitary colorectal liver metastasis. J. Clin. Gastroenterol., 42; 2008, 945–999.

26. Howard, J. H., Treng, C. W., Smith, J. K., Eckhoff, D. E., Bynan, J. S., Wang, T., Arnoletti, J. P., Heslin, M. J. Radiofrequency ablation for unresectable tumor sof the liver. Am. Surg., 74; 2008, 594–600.

Labels
Surgery Orthopaedics Trauma surgery
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#